Stanford Engineering Magazine | Issue #39
Scroll to Explore
Jan 31 2018
A new kind of homing beacon targets cancerous cells and other diseases
By reprogramming a type of chemical receptor found on virtually all human cells, a researcher hopes to bioengineer treatments for diseases such as Parkinson’s and cancer.
